TerrAscend Corp. (OTC: TSNDF), a cannabis company with a presence in several states, reported its financial performance for the first quarter that ended March 31, 2024 with gains in revenue and operational efficiency.
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced the pricing of an underwritten public offering of 8,275,000 shares of its common stock at a price to the public of $21.00 per share and, in lieu of